580 artigos
A completed trial compares laparoscopic adrenal removal to intensive drug therapy for subclinical cortisol-secreting incidentalomas and cardiovascular risk.
A completed RCT tests whether trained non-clinicians can guide self-help CBT for generalized anxiety disorder in seniors.
A 3-month interval cycling program assessed cardiovascular and metabolic improvements in obese vs. normal-weight women.
A randomized trial pits functional training, stationary cycling, and Xbox Kinect exergaming against each other in elderly Parkinson's patients.
A completed trial of 69 coronary artery disease patients compares HIIT and moderate continuous training on fitness, activity, and quality of life.
A Phase IIa trial explores whether the HIF-PHI drug daprodustat can safely replace EPO injections in hemodialysis patients with anemia.
A landmark Phase 3 trial evaluates whether omecamtiv mecarbil, a cardiac myosin activator, reduces cardiovascular death in HFrEF patients.
A Phase 4 real-world study comparing extended-release methylphenidate formulations for ADHD was terminated before yielding conclusions.
A phase 3 trial adding ERN/LRPT to statin therapy for dyslipidemia was terminated early, raising questions about the drug's clinical future.
NIDCR researchers compared stromal cells from bone marrow, skin, spleen, and fat to identify which best regenerates bone and supports blood formation.
A 10-week supervised strength program targets chronic inflammation and self-efficacy in long-term allogeneic HCT survivors.
A terminated RCT explored whether immunotype-targeted supplements could reduce iAge®, an AI-derived biomarker of chronic inflammation and immune aging.
